Cargando…

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series

Detalles Bibliográficos
Autores principales:	Martora, Fabrizio, Fabbrocini, Gabriella, Marasca, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286452/ https://www.ncbi.nlm.nih.gov/pubmed/34816549 http://dx.doi.org/10.1111/dth.15225

Ejemplares similares

mRNA-1273: Pityriasis rosea: case report
Publicado: (2022)

Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
por: Shin, Sun Hye, et al.
Publicado: (2022)

Acral pityriasis rosea: A rare variant of pityriasis rosea
por: Tantanasrigul, Pimpa, et al.
Publicado: (2021)

Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
por: Wang, Chii-Shyan, et al.
Publicado: (2022)

Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine
por: Martora, Fabrizio, et al.
Publicado: (2022)

“Covid arm”: Abnormal side effect after Moderna COVID‐19 vaccine
por: Picone, Vincenzo, et al.
Publicado: (2021)

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
por: Martora, Fabrizio, et al.
Publicado: (2022)

Unilateral pityriasis rosea
por: Ataseven, Arzu, et al.
Publicado: (2014)

“PiMa sign”: A possible correlation between dermographism and pityriasis versicolor?
por: Martora, Fabrizio, et al.
Publicado: (2022)

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID‐19 vaccine: Controversial immune effects
por: Martora, Fabrizio, et al.
Publicado: (2022)

Pityriasis rosea following human papillomavirus vaccination()
por: Drago, Francesco, et al.
Publicado: (2014)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
por: Drago, Francesco, et al.
Publicado: (2022)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

A case series of erythema multiforme-like pityriasis rosea
por: Das, Anupam, et al.
Publicado: (2016)

Pityriasis Rosea
Publicado: (1908)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Polymorphic pityriasis rosea precipitating psoriasis
por: Sacchidanand, Sarvajnamurthy, et al.
Publicado: (2013)

Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
por: Drago, Francesco, et al.
Publicado: (2018)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
por: Chow, Sin Yu, et al.
Publicado: (2022)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

GIANT PITYRIASIS ROSEA
por: Zawar, Vijay
Publicado: (2010)

The Treatment of Pityriasis Rosea
por: Maplestone, P. A., et al.
Publicado: (1937)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Is a treatment for pityriasis rosea really needed?
por: Ciccarese, Giulia, et al.
Publicado: (2016)

From the Cochrane Library: Interventions for Pityriasis Rosea
por: Méndez, Alejandra, et al.
Publicado: (2023)

Nomenclature of drug-induced pityriasis rosea-like rashes
por: Chuh, Antonio AT
Publicado: (2015)

Pityriasis Rosea Following Covaxin (BBV152) Vaccination for COVID-19
por: Singh, Bhabani S. T. P., et al.
Publicado: (2022)

Pityriasis rosea, pityriasis rosea–like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022)

Manifestation of pityriasis rosea and pityriasis rosea‐like eruptions after Covid‐19 vaccine: A systematic review
por: Khan, Iman, et al.
Publicado: (2023)

Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021)

New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
por: Kaminetsky, Joshua, et al.
Publicado: (2021)

Pityriasis Rosea Induced by COVID-19 Vaccination
por: Khattab, Elina, et al.
Publicado: (2022)

Clinical variants of pityriasis rosea
por: Urbina, Francisco, et al.
Publicado: (2017)

Dupilumab-induced pityriasis rosea
por: Zabel, Morgan, et al.
Publicado: (2023)

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t2knrh2uisu2s9gbmmm3nj1ii2